Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Operating Expenses | 6,513 | 4,607 | 5,372 | 5,247 | 5,374 |
| Operating Income | -6,513 | -4,607 | -5,372 | -5,247 | -5,374 |
| Interest Expense | 698 | 394 | 219 | 202 | 249 |
| Other Income | 22 | 1,653 | -124 | 27 | 15 |
| Pre-tax Income | -7,189 | -3,348 | -5,714 | -5,423 | -5,609 |
| Net Income Continuous | -7,189 | -3,348 | -5,714 | -5,423 | -5,609 |
| Net Income | $-7,189 | $-3,348 | $-5,714 | $-5,423 | $-5,609 |
| EPS Basic Total Ops | -0.43 | -9.32 | -0.36 | -5.93 | -6.16 |
| EPS Basic Continuous Ops | -0.43 | -3.53 | -6.16 | -5.93 | -6.16 |
| EPS Diluted Total Ops | -0.43 | -9.32 | -0.36 | -5.93 | -6.16 |
| EPS Diluted Continuous Ops | -0.43 | -3.53 | -6.16 | -5.93 | -6.16 |
| EBITDA(a) | $-6,412 | $-4,542 | $-5,308 | $-5,176 | $-5,317 |